Anthocyanins (160 mg/day for 12 weeks) were shown to decrease pro-inflammatory cytokines, including caspase-1, IL-1β, and IL-18, in NAFLD patients [79]. Here, IL18 is linked to metabolic dysfunction-associated steatotic liver disease.